Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • European Commission

Tag: European Commission

Rasonque EU approval infographic showing daraxonrasib survival of 13.2 months versus 6.7 months on chemotherapy
  • Pharmaceuticals

Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer

Megan Wood3 hours ago010 mins

The European Commission has approved Revolution Medicines’ Rasonque (daraxonrasib) for previously treated metastatic pancreatic cancer, with or without a RAS mutation. Here is what the label covers and when patients may get it.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (368)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (116)
  • Uncategorized (1)

Recent Posts

  • MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare
  • Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer
  • Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives
  • Savara Molgramostim FDA Decision Delayed: No New Date for First aPAP Drug
  • Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.